Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group

: The HLA‐B5/35 cross‐reacting group (CREG) is a set of closely related antigens including HLA‐B35, B51, B52, B53 and B78. The nucleotide sequences of exon 1 through 5 of the B5/35 CREG were determined to assess the level of polymorphism. For exons 2 and 3, the previously described sequence‐based ty...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tissue antigens 2002-09, Vol.60 (3), p.224-234
Hauptverfasser: Swelsen, W.T.N., Voorter, C.E.M., Van Den Berg-Loonen, E.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 234
container_issue 3
container_start_page 224
container_title Tissue antigens
container_volume 60
creator Swelsen, W.T.N.
Voorter, C.E.M.
Van Den Berg-Loonen, E.M.
description : The HLA‐B5/35 cross‐reacting group (CREG) is a set of closely related antigens including HLA‐B35, B51, B52, B53 and B78. The nucleotide sequences of exon 1 through 5 of the B5/35 CREG were determined to assess the level of polymorphism. For exons 2 and 3, the previously described sequence‐based typing (SBT) strategy was applied, the nucleotide sequences of exon 1, 4 and 5 were determined by allele‐specific sequencing. A total of 225 unrelated individuals were HLA‐B typed by heterozygous sequencing of exons 2 and 3. In the B5/35 CREG, 26 different alleles were identified, whereas 63 non‐B5/35 CREG alleles were sequenced. The SBT strategy was proven to be reliable and efficient for high resolution typing of the B5/35 CREG. The nucleotide sequences of exon 1, 4 and 5 were determined for the 26 different B5/35 CREG alleles to establish the level of polymorphism. For seven different alleles, of which the exon 1, 4 and 5 sequences were hitherto unknown, the sequences were elucidated and in agreement with the known B5/35 sequences. Nineteen HLA‐B5/35 CREG alleles with previously published exon 1, 4 and 5 sequences were sequenced in at least two individuals. Three new alleles were identified. The first, B*5204, showed a difference at position 200 compared to B*52011, which was previously considered a conserved position. The other two alleles, B*3542 and B*51015, showed exon 2 and 3 sequences identical to B*35011 and B*51011, but differences in exons 1 and 4, respectively. B*3542 had differences at position 25 and 72 and B*51015 showed a difference at position 636. More polymorphism might be present outside exons 2 and 3 than previously thought.
doi_str_mv 10.1034/j.1399-0039.2002.600304.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72705794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72705794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4904-bd8c1f313e0256b7b82022d56b989682f66bc952ca31b74daadf891076ae4213</originalsourceid><addsrcrecordid>eNqNkEtv2zAQhImgQewm-QsFc-nJUpZv8VbbyBNGmiAG3BtBSVQiV5Yc0Ubsf18qMtJje-IQMzuL_RC6IBATYPxyGROmdQTAdEwBaCyDBB7vjtDw0_mChgBAIpoQMUBfvV-GH1dan6ABoZwLBmKInp7d29bVmcO2ttXelx43BXa7pvaYjDAdYTbCPJg5Fp2zeXX4djaOJuKSCZy1jfdR62y2KesX_NI22_UZOi5s5d354T1F8-ur-fQ2mv28uZuOZ1HGNfAozZOMFIwwB1TIVKUJBUrzIHWiZUILKdNMC5pZRlLFc2vzItEElLSOU8JO0fe-dt024QK_MavSZ66qbO2arTeKKhBK838GSaKZpESGoO6DH1e1rjDrtlzZdm8ImI67WZqOrunomo676bmbXZj9dliyTVcu_zt5AB0CP_rAe1m5_f83m_n4odehIuorSr9xu88K2_42UjElzOLhxjyK66f7RTIxv9gfHxucGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18936216</pqid></control><display><type>article</type><title>Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Swelsen, W.T.N. ; Voorter, C.E.M. ; Van Den Berg-Loonen, E.M.</creator><creatorcontrib>Swelsen, W.T.N. ; Voorter, C.E.M. ; Van Den Berg-Loonen, E.M.</creatorcontrib><description>: The HLA‐B5/35 cross‐reacting group (CREG) is a set of closely related antigens including HLA‐B35, B51, B52, B53 and B78. The nucleotide sequences of exon 1 through 5 of the B5/35 CREG were determined to assess the level of polymorphism. For exons 2 and 3, the previously described sequence‐based typing (SBT) strategy was applied, the nucleotide sequences of exon 1, 4 and 5 were determined by allele‐specific sequencing. A total of 225 unrelated individuals were HLA‐B typed by heterozygous sequencing of exons 2 and 3. In the B5/35 CREG, 26 different alleles were identified, whereas 63 non‐B5/35 CREG alleles were sequenced. The SBT strategy was proven to be reliable and efficient for high resolution typing of the B5/35 CREG. The nucleotide sequences of exon 1, 4 and 5 were determined for the 26 different B5/35 CREG alleles to establish the level of polymorphism. For seven different alleles, of which the exon 1, 4 and 5 sequences were hitherto unknown, the sequences were elucidated and in agreement with the known B5/35 sequences. Nineteen HLA‐B5/35 CREG alleles with previously published exon 1, 4 and 5 sequences were sequenced in at least two individuals. Three new alleles were identified. The first, B*5204, showed a difference at position 200 compared to B*52011, which was previously considered a conserved position. The other two alleles, B*3542 and B*51015, showed exon 2 and 3 sequences identical to B*35011 and B*51011, but differences in exons 1 and 4, respectively. B*3542 had differences at position 25 and 72 and B*51015 showed a difference at position 636. More polymorphism might be present outside exons 2 and 3 than previously thought.</description><identifier>ISSN: 0001-2815</identifier><identifier>EISSN: 1399-0039</identifier><identifier>DOI: 10.1034/j.1399-0039.2002.600304.x</identifier><identifier>PMID: 12445305</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>35 CREG ; Alleles ; Base Sequence ; Cross Reactions ; Exons - genetics ; exons 1-5 ; HLA-B ; HLA-B Antigens - genetics ; HLA-B Antigens - immunology ; HLA-B35 Antigen - genetics ; HLA-B35 Antigen - immunology ; Humans ; Molecular Sequence Data ; Polymorphism, Genetic ; Sequence Analysis, DNA ; sequence-based typing</subject><ispartof>Tissue antigens, 2002-09, Vol.60 (3), p.224-234</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4904-bd8c1f313e0256b7b82022d56b989682f66bc952ca31b74daadf891076ae4213</citedby><cites>FETCH-LOGICAL-c4904-bd8c1f313e0256b7b82022d56b989682f66bc952ca31b74daadf891076ae4213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1034%2Fj.1399-0039.2002.600304.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1034%2Fj.1399-0039.2002.600304.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12445305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swelsen, W.T.N.</creatorcontrib><creatorcontrib>Voorter, C.E.M.</creatorcontrib><creatorcontrib>Van Den Berg-Loonen, E.M.</creatorcontrib><title>Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group</title><title>Tissue antigens</title><addtitle>Tissue Antigens</addtitle><description>: The HLA‐B5/35 cross‐reacting group (CREG) is a set of closely related antigens including HLA‐B35, B51, B52, B53 and B78. The nucleotide sequences of exon 1 through 5 of the B5/35 CREG were determined to assess the level of polymorphism. For exons 2 and 3, the previously described sequence‐based typing (SBT) strategy was applied, the nucleotide sequences of exon 1, 4 and 5 were determined by allele‐specific sequencing. A total of 225 unrelated individuals were HLA‐B typed by heterozygous sequencing of exons 2 and 3. In the B5/35 CREG, 26 different alleles were identified, whereas 63 non‐B5/35 CREG alleles were sequenced. The SBT strategy was proven to be reliable and efficient for high resolution typing of the B5/35 CREG. The nucleotide sequences of exon 1, 4 and 5 were determined for the 26 different B5/35 CREG alleles to establish the level of polymorphism. For seven different alleles, of which the exon 1, 4 and 5 sequences were hitherto unknown, the sequences were elucidated and in agreement with the known B5/35 sequences. Nineteen HLA‐B5/35 CREG alleles with previously published exon 1, 4 and 5 sequences were sequenced in at least two individuals. Three new alleles were identified. The first, B*5204, showed a difference at position 200 compared to B*52011, which was previously considered a conserved position. The other two alleles, B*3542 and B*51015, showed exon 2 and 3 sequences identical to B*35011 and B*51011, but differences in exons 1 and 4, respectively. B*3542 had differences at position 25 and 72 and B*51015 showed a difference at position 636. More polymorphism might be present outside exons 2 and 3 than previously thought.</description><subject>35 CREG</subject><subject>Alleles</subject><subject>Base Sequence</subject><subject>Cross Reactions</subject><subject>Exons - genetics</subject><subject>exons 1-5</subject><subject>HLA-B</subject><subject>HLA-B Antigens - genetics</subject><subject>HLA-B Antigens - immunology</subject><subject>HLA-B35 Antigen - genetics</subject><subject>HLA-B35 Antigen - immunology</subject><subject>Humans</subject><subject>Molecular Sequence Data</subject><subject>Polymorphism, Genetic</subject><subject>Sequence Analysis, DNA</subject><subject>sequence-based typing</subject><issn>0001-2815</issn><issn>1399-0039</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtv2zAQhImgQewm-QsFc-nJUpZv8VbbyBNGmiAG3BtBSVQiV5Yc0Ubsf18qMtJje-IQMzuL_RC6IBATYPxyGROmdQTAdEwBaCyDBB7vjtDw0_mChgBAIpoQMUBfvV-GH1dan6ABoZwLBmKInp7d29bVmcO2ttXelx43BXa7pvaYjDAdYTbCPJg5Fp2zeXX4djaOJuKSCZy1jfdR62y2KesX_NI22_UZOi5s5d354T1F8-ur-fQ2mv28uZuOZ1HGNfAozZOMFIwwB1TIVKUJBUrzIHWiZUILKdNMC5pZRlLFc2vzItEElLSOU8JO0fe-dt024QK_MavSZ66qbO2arTeKKhBK838GSaKZpESGoO6DH1e1rjDrtlzZdm8ImI67WZqOrunomo676bmbXZj9dliyTVcu_zt5AB0CP_rAe1m5_f83m_n4odehIuorSr9xu88K2_42UjElzOLhxjyK66f7RTIxv9gfHxucGg</recordid><startdate>200209</startdate><enddate>200209</enddate><creator>Swelsen, W.T.N.</creator><creator>Voorter, C.E.M.</creator><creator>Van Den Berg-Loonen, E.M.</creator><general>Munksgaard International Publishers</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200209</creationdate><title>Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group</title><author>Swelsen, W.T.N. ; Voorter, C.E.M. ; Van Den Berg-Loonen, E.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4904-bd8c1f313e0256b7b82022d56b989682f66bc952ca31b74daadf891076ae4213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>35 CREG</topic><topic>Alleles</topic><topic>Base Sequence</topic><topic>Cross Reactions</topic><topic>Exons - genetics</topic><topic>exons 1-5</topic><topic>HLA-B</topic><topic>HLA-B Antigens - genetics</topic><topic>HLA-B Antigens - immunology</topic><topic>HLA-B35 Antigen - genetics</topic><topic>HLA-B35 Antigen - immunology</topic><topic>Humans</topic><topic>Molecular Sequence Data</topic><topic>Polymorphism, Genetic</topic><topic>Sequence Analysis, DNA</topic><topic>sequence-based typing</topic><toplevel>online_resources</toplevel><creatorcontrib>Swelsen, W.T.N.</creatorcontrib><creatorcontrib>Voorter, C.E.M.</creatorcontrib><creatorcontrib>Van Den Berg-Loonen, E.M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Tissue antigens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swelsen, W.T.N.</au><au>Voorter, C.E.M.</au><au>Van Den Berg-Loonen, E.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group</atitle><jtitle>Tissue antigens</jtitle><addtitle>Tissue Antigens</addtitle><date>2002-09</date><risdate>2002</risdate><volume>60</volume><issue>3</issue><spage>224</spage><epage>234</epage><pages>224-234</pages><issn>0001-2815</issn><eissn>1399-0039</eissn><abstract>: The HLA‐B5/35 cross‐reacting group (CREG) is a set of closely related antigens including HLA‐B35, B51, B52, B53 and B78. The nucleotide sequences of exon 1 through 5 of the B5/35 CREG were determined to assess the level of polymorphism. For exons 2 and 3, the previously described sequence‐based typing (SBT) strategy was applied, the nucleotide sequences of exon 1, 4 and 5 were determined by allele‐specific sequencing. A total of 225 unrelated individuals were HLA‐B typed by heterozygous sequencing of exons 2 and 3. In the B5/35 CREG, 26 different alleles were identified, whereas 63 non‐B5/35 CREG alleles were sequenced. The SBT strategy was proven to be reliable and efficient for high resolution typing of the B5/35 CREG. The nucleotide sequences of exon 1, 4 and 5 were determined for the 26 different B5/35 CREG alleles to establish the level of polymorphism. For seven different alleles, of which the exon 1, 4 and 5 sequences were hitherto unknown, the sequences were elucidated and in agreement with the known B5/35 sequences. Nineteen HLA‐B5/35 CREG alleles with previously published exon 1, 4 and 5 sequences were sequenced in at least two individuals. Three new alleles were identified. The first, B*5204, showed a difference at position 200 compared to B*52011, which was previously considered a conserved position. The other two alleles, B*3542 and B*51015, showed exon 2 and 3 sequences identical to B*35011 and B*51011, but differences in exons 1 and 4, respectively. B*3542 had differences at position 25 and 72 and B*51015 showed a difference at position 636. More polymorphism might be present outside exons 2 and 3 than previously thought.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>12445305</pmid><doi>10.1034/j.1399-0039.2002.600304.x</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-2815
ispartof Tissue antigens, 2002-09, Vol.60 (3), p.224-234
issn 0001-2815
1399-0039
language eng
recordid cdi_proquest_miscellaneous_72705794
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 35 CREG
Alleles
Base Sequence
Cross Reactions
Exons - genetics
exons 1-5
HLA-B
HLA-B Antigens - genetics
HLA-B Antigens - immunology
HLA-B35 Antigen - genetics
HLA-B35 Antigen - immunology
Humans
Molecular Sequence Data
Polymorphism, Genetic
Sequence Analysis, DNA
sequence-based typing
title Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A21%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sequence%20analysis%20of%20exons%201,%202,%203,%204%20and%205%20of%20the%20HLA-B5/35%20cross-reacting%20group&rft.jtitle=Tissue%20antigens&rft.au=Swelsen,%20W.T.N.&rft.date=2002-09&rft.volume=60&rft.issue=3&rft.spage=224&rft.epage=234&rft.pages=224-234&rft.issn=0001-2815&rft.eissn=1399-0039&rft_id=info:doi/10.1034/j.1399-0039.2002.600304.x&rft_dat=%3Cproquest_cross%3E72705794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18936216&rft_id=info:pmid/12445305&rfr_iscdi=true